BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2004
View Archived Issues
Sanofi-Synthelabo updates first quarter progress
Read More
Antitumor effects of second-generation immunomodulatory oligonucleotides
Read More
Gilead's HIV franchise continues to move forward
Read More
BioTie highlights developments during interim period
Read More
Salix continued progress during first three months of 2004
Read More
Seattle Genetics achieves significant milestones during first quarter
Read More
Fluoxetine reported to increase systemic exposure to ramelteon
Read More
Potential use of antidepressants in patients with IBS
Read More
AstraZeneca reports new, highly potent iNOS inhibitors
Read More
Nuvelo restarts phase IIa trial with rNAPc2
Read More
Roche and Syrrx to develop drugs for cancer and diabetes
Read More
Viragen and University of Miami advance cancer study
Read More
InKine completes enrollment in phase II study of INKP-102
Read More
NovaRx receives new SBIR grant from NIH
Read More
Millennium begins phase II trial of Velcade-rituximab combination therapy
Read More
Juvaris and SomaGenics enter collaboration for combination product
Read More
InterMune begins phase II trial of Infergen/Actimmune combination therapy
Read More
Novogen commences phase Ia trial with anticancer drug NV-18
Read More
Active Biotech and Avidex collaboration to create potent anticancer agents
Read More
European Commission broadens Ferriprox indication
Read More
FDA advisory panel recommends rejection of Genasense NDA
Read More
Axcan to begin phase III clinical trials with Itax
Read More
GlycoGenesys begins phase I trial with GCS-100LE
Read More
Spotlight on duloxetine in depression and diabetic neuropathic pain
Read More
Efalizumab: Efficacy, safety and effects on quality of life in psoriasis
Read More
Memory presents new alpha7 nAChR agonists and their therapeutic use
Read More
BMS scientists describe new chemokine CCR3 ligands for asthma and other disorders
Read More
Novel SERMs prepared and tested by Lilly researchers
Read More
Merck patent covers pyrimidine-based cannabinoid CB1 antagonists/inverse agonists
Read More
New PI3K-gamma inhibitors discovered by Bayer scientists
Read More
New anti-hepatitis B virus agents claimed by LG Life Sciences
Read More
Oral simvastatin treatment against relapsing-remitting multiple sclerosis
Read More